NYSE:CE

Stock Analysis Report

Executive Summary

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally.

Snowflake

Fundamentals

Established dividend payer and fair value.


Similar Companies

Share Price & News

How has Celanese's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.8%

CE

2.2%

US Chemicals

1.3%

US Market


1 Year Return

23.0%

CE

-7.5%

US Chemicals

5.9%

US Market

Return vs Industry: CE exceeded the US Chemicals industry which returned -7.5% over the past year.

Return vs Market: CE exceeded the US Market which returned 5.9% over the past year.


Shareholder returns

CEIndustryMarket
7 Day0.8%2.2%1.3%
30 Day-4.0%-3.6%-1.9%
90 Day11.5%-2.8%-1.8%
1 Year25.7%23.0%6.3%-7.5%8.3%5.9%
3 Year101.1%89.4%41.6%15.6%45.6%36.2%
5 Year140.4%118.0%43.5%12.4%66.1%47.9%

Price Volatility Vs. Market

How volatile is Celanese's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Celanese undervalued compared to its fair value and its price relative to the market?

8.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: CE ($120.44) is trading below our estimate of fair value ($131.11)

Significantly Undervalued: CE is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: CE is good value based on its PE Ratio (14.9x) compared to the Chemicals industry average (18.9x).

PE vs Market: CE is good value based on its PE Ratio (14.9x) compared to the US market (17.5x).


Price to Earnings Growth Ratio

Low PEG Ratio: CE is poor value based on its PEG Ratio (1.4x)


Price to Book Ratio

PB vs Industry: CE is overvalued based on its PB Ratio (5.2x) compared to the US Chemicals industry average (2x).


Next Steps

Future Growth

How is Celanese forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?

10.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CE's forecast earnings growth (10.6% per year) is above the savings rate (2.7%).

Earnings vs Market: CE's earnings (10.6% per year) are forecast to grow slower than the US market (14.4% per year).

High Growth Earnings: CE's earnings are forecast to grow, but not significantly.

Revenue vs Market: CE's revenue (4.3% per year) is forecast to grow slower than the US market (7.3% per year).

High Growth Revenue: CE's revenue (4.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: CE's Return on Equity is forecast to be high in 3 years time (38.7%)


Next Steps

Past Performance

How has Celanese performed over the past 5 years?

9.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: CE's earnings have grown by 9.9% per year over the past 5 years.

Accelerating Growth: CE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CE had negative earnings growth (-8%) over the past year, making it difficult to compare to the Chemicals industry average (-2%).


Return on Equity

High ROE: Whilst CE's Return on Equity (32.45%) is high, this metric is skewed due to their high level of debt.


Return on Assets

ROA vs Industry: CE has a higher Return on Assets than the Chemicals industry average last year.


Return on Capital Employed

ROCE Improving: CE has significantly improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Celanese's financial position?


Financial Position Analysis

Short Term Liabilities: CE's short term assets ($2.9B) exceeds its short term liabilities ($1.4B)

Long Term Liabilities: CE's short term assets (2.9B) do not cover its long term liabilities (4.8B)


Debt to Equity History and Analysis

Debt Level: CE's debt to equity ratio (110.8%) is considered high

Reducing Debt: CE's debt to equity ratio has increased from 98.3% to 110.8% over the past 5 years.

Debt Coverage: CE's debt is well covered by operating cash flow (43.3%).

Interest Coverage: Insufficient data to determine if CE's interest payments on its debt are well covered by EBIT.


Balance Sheet

Inventory Level: CE has a high level of physical assets or inventory.

Debt Coverage by Assets: CE's debt is not covered by short term assets (assets are 0.8x debt).


Next Steps

Dividend

What is Celanese's current dividend yield, its reliability and sustainability?

2.06%

Current Dividend Yield


Dividend Yield vs Market

company2.1%marketbottom25%1.5%markettop25%3.8%industryaverage2.2%forecastin3Years2.2%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: CE's dividend (2.06%) is higher than the bottom 25% of dividend payers in the US market (1.47%).

High Dividend: CE's dividend (2.06%) is low compared to the top 25% of dividend payers in the US market (3.77%).

Stable Dividend: CE's dividends per share have been stable in the past 10 years.

Growing Dividend: CE's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (27.6%), CE's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CE's dividends in 3 years are forecast to be well covered by earnings (23.2% payout ratio).


Next Steps

Management

What is the CEO of Celanese's salary, the management and board of directors tenure and is there insider trading?

1.6yrs

Average management tenure


CEO

Lori Ryerkerk (56yo)

0.4yrs

Tenure

0

Ms. Lori J. Ryerkerk, BS, serves as Chief Executive Officer and Director of Celanese Corporation since May 1, 2019. She served as an Executive Vice President, Global Manufacturing for Royal Dutch Shell (Sh ...


Management Age and Tenure

1.6yrs

Average Tenure

49yo

Average Age

Experienced Management: CE's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Age and Tenure

5.0yrs

Average Tenure

64yo

Average Age

Experienced Board: CE's board of directors are considered experienced (5 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellUS$993,81029 Apr 19
John Wulff
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares9,175
Max PriceUS$108.32

Ownership Breakdown


Management Team

  • Mark Rohr (68yo)

    Executive Chairman & President

    • Tenure: 7.5yrs
    • Compensation: US$12.51m
  • Lori Ryerkerk (56yo)

    CEO & Director

    • Tenure: 0.4yrs
  • Lynne Puckett

    Senior VP & General Counsel

    • Tenure: 0.7yrs
  • Scott Richardson (42yo)

    Senior VP & CFO

    • Tenure: 1.7yrs
    • Compensation: US$2.42m
  • Todd Elliott

    Senior Vice President of Acetyls

    • Tenure: 0yrs
  • Benita Casey

    Chief Accounting Officer

    • Tenure: 1.5yrs
  • Verghese Thomas

    VP and Chief Technology & Innovation Officer

    • Tenure: 3.3yrs
  • Kevin Oliver (47yo)

    Chief Financial Officer for European Headquarters

    • Tenure: 1.5yrs
    • Compensation: US$3.67m
  • Shannon Jurecka (49yo)

    Senior VP & Chief Human Resources Officer

    • Tenure: 2.3yrs
    • Compensation: US$1.86m
  • Surabhi Varshney

    Vice President of Investor Relations

    • Tenure: 0yrs

Board Members

  • Jean Blackwell (64yo)

    Independent Director

    • Tenure: 5.7yrs
    • Compensation: US$269.89k
  • John Wulff (70yo)

    Independent Director

    • Tenure: 13.2yrs
    • Compensation: US$274.89k
  • Mark Rohr (68yo)

    Executive Chairman & President

    • Tenure: 7.5yrs
    • Compensation: US$12.51m
  • Edward Galante (68yo)

    Lead Independent Director

    • Tenure: 2.7yrs
    • Compensation: US$284.89k
  • Jay Ihlenfeld (67yo)

    Independent Director

    • Tenure: 7.7yrs
    • Compensation: US$269.89k
  • Lori Ryerkerk (56yo)

    CEO & Director

    • Tenure: 0.4yrs
  • Bill Brown (56yo)

    Independent Director

    • Tenure: 3.8yrs
    • Compensation: US$254.89k
  • Kathy Hill (62yo)

    Independent Director

    • Tenure: 4.3yrs
    • Compensation: US$274.89k
  • Kim Rucker (52yo)

    Director

    • Tenure: 1yrs
    • Compensation: US$112.55k
  • David Hoffmeister (64yo)

    Independent Director

    • Tenure: 13.8yrs
    • Compensation: US$254.89k

Company Information

Celanese Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Celanese Corporation
  • Ticker: CE
  • Exchange: NYSE
  • Founded: 1918
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: US$14.903b
  • Shares outstanding: 123.74m
  • Website: https://www.celanese.com

Number of Employees


Location

  • Celanese Corporation
  • 222 West Las Colinas Boulevard
  • Suite 900N
  • Irving
  • Texas
  • 75039
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CENYSE (New York Stock Exchange)YesCommon StockUSUSDJan 2005
DG3DB (Deutsche Boerse AG)YesCommon StockDEEURJan 2005
0HURLSE (London Stock Exchange)YesCommon StockGBUSDJan 2005

Biography

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through Engine ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 23:47
End of Day Share Price2019/10/14 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.